Mark Hyman Rapaport
#158,623
Most Influential Person Now
Researcher
Mark Hyman Rapaport's AcademicInfluence.com Rankings
Mark Hyman Rapaportcomputer-science Degrees
Computer Science
#8922
World Rank
#9378
Historical Rank
Artificial Intelligence
#4103
World Rank
#4161
Historical Rank
Database
#5919
World Rank
#6138
Historical Rank
Download Badge
Computer Science
Mark Hyman Rapaport's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Mark Hyman Rapaport Influential?
(Suggest an Edit or Addition)Mark Hyman Rapaport's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Quality-of-life impairment in depressive and anxiety disorders. (2005) (834)
- Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. (2001) (537)
- Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. (1996) (523)
- Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial (2005) (517)
- Subsyndromal symptomatic depression: a new mood disorder? (1994) (409)
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
- TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. (2005) (328)
- A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. (2001) (283)
- Quality of Life: The Ultimate Outcome Measure of Interventions in Major Depressive Disorder (2011) (269)
- Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology (2021) (240)
- Clinical and Physiological Consequences of Rapid Tryptophan Depletion (2000) (217)
- Inflammation as a Predictive Biomarker for Response to Omega-3 Fatty Acids in Major Depressive Disorder: A Proof of Concept Study (2015) (212)
- C-reactive protein levels in schizophrenia: a review and meta-analysis. (2014) (195)
- Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals (2019) (176)
- Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. (1998) (168)
- A descriptive analysis of minor depression. (2002) (162)
- Rare coding variants in ten genes confer substantial risk for schizophrenia (2022) (154)
- Moclobemide in social phobia: a controlled dose-response trial. (1997) (153)
- Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder (2012) (150)
- Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder (2017) (136)
- Effects of the acute administration of caffeine in patients with schizophrenia (1990) (122)
- Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores (2004) (121)
- Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia (2005) (120)
- Escitalopram continuation treatment prevents relapse of depressive episodes. (2004) (119)
- Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies (2013) (118)
- Treating Major Depression by Creating Positive Expectations for the Future: A Pilot Study for the Effectiveness of Future‐Directed Therapy (FDT) on Symptom Severity and Quality of Life (2012) (115)
- A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. (1997) (114)
- Efficacy of controlled-release paroxetine in the treatment of late-life depression. (2003) (113)
- Magnitude of placebo response and drug–placebo differences across psychiatric disorders (2004) (113)
- Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. (2002) (112)
- Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. (1996) (112)
- Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. (1997) (101)
- The effects of lithium on ex vivo cytokine production (2001) (98)
- The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. (2009) (96)
- Immune parameters in rapid cycling bipolar patients before and after lithium treatment. (1999) (93)
- Effects of a Tryptophan-Free Amino Acid Drink Challenge on Normal Human Sleep Electroencephalogram and Mood (1998) (84)
- Diet, Stress and Mental Health (2020) (82)
- A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting (2013) (80)
- Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation (2006) (80)
- Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. (2001) (79)
- Quality of well being in panic disorder: the assessment of psychiatric and general disability. (2000) (79)
- A preliminary study of the effects of a single session of Swedish massage on hypothalamic-pituitary-adrenal and immune function in normal individuals. (2010) (78)
- Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. (2004) (76)
- Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. (1998) (74)
- 148th Annual Meeting of the American Psychiatric Association (1996) (71)
- Impact of systemic lupus erythematosus on health, family, and work: The patient perspective (2010) (70)
- Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies (2017) (69)
- Classification and treatment of sub-threshold depression (2006) (67)
- Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry (2019) (65)
- A neuropsychological study of panic disorder: negative findings. (1998) (63)
- Attitude toward humor in patients experiencing depressive symptoms. (2011) (63)
- Immune parameters in euthymic bipolar patients and normal volunteers. (1994) (63)
- Increased serum soluble interleukin-2 receptors in caucasian and Korean schizophrenic patients (1994) (62)
- Deficits in Psychological Well‐Being and Quality‐of‐Life in Minor Depression: Implications for DSM‐V (2010) (62)
- The genomic psychiatry cohort: Partners in discovery (2013) (61)
- Sleep estimation from wrist activity in patients with major depression (2000) (60)
- A preliminary study of the effects of repeated massage on hypothalamic-pituitary-adrenal and immune function in healthy individuals: a study of mechanisms of action and dosage. (2012) (60)
- Temperament in the clinical differentiation of depressed bipolar and unipolar major depressive patients. (2005) (60)
- Clinical Features and Functioning of Patients with Minor Depression (2008) (58)
- The Effects of Transdermal Nicotine Therapy for Smoking Cessation on Depressive Symptoms in Patients with Major Depression (2001) (57)
- An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. (2001) (55)
- A case-control study on the socio-demographic characteristics of 53 neonaticidal mothers. (1998) (55)
- CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers (1997) (53)
- The Impact of Psychotherapy, Pharmacotherapy, and Their Combination on Quality of Life in Depression (2011) (52)
- Prevalence, recognition, and treatment of comorbid depression and anxiety. (2001) (51)
- The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo. (2011) (49)
- A quantitative neuromotor predictor of antidepressant non-response in patients with major depression. (2003) (49)
- Massage therapy decreases cancer‐related fatigue: Results from a randomized early phase trial (2018) (48)
- Is placebo response the same as drug response in panic disorder? (2000) (48)
- Sertraline treatment of panic disorder: results of a long‐term study (2001) (47)
- Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia. (2009) (46)
- Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. (2007) (45)
- A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. (2006) (43)
- Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings (2017) (43)
- Omega-3 fatty acids and depression: from cellular mechanisms to clinical care. (2011) (43)
- Serum cytokine and soluble interleukin-2 receptors in patients with panic disorder. (1994) (42)
- Genetic linkage study of bipolar disorder and the serotonin transporter. (1996) (42)
- Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation (2007) (42)
- Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits (2020) (39)
- Neonaticide in the city of Rio de Janeiro: forensic and psycholegal perspectives. (1999) (39)
- No antidepressant effect of biperiden compared with placebo in depression: A double-blind 6-week clinical trial (1995) (38)
- Circulating Lymphocyte Phenotypic Surface Markers in Anxiety Disorder Patients and Normal Volunteers (1998) (38)
- Sociodemographic predictors of temperament and character. (2000) (38)
- Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases (2018) (36)
- Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally? (2000) (36)
- Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future (2017) (35)
- Gender differences in outpatient research subjects with affective disorders: a comparison of descriptive variables. (1995) (35)
- Absence of Neuropsychologic Deficits in Patients Receiving Long-Term Treatment With Alprazolam-XR for Panic Disorder (2001) (33)
- Rapid tryptophan depletion reverses phenelzine‐induced suppression of REM sleep (2003) (33)
- Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. (2002) (32)
- Ipsapirone, a 5-HT1A Agonist, Suppresses REM Sleep Equally in Unmedicated Depressed Patients and Normal Controls (1996) (32)
- Validation of the Scale of Functioning in Older Outpatients With Schizophrenia. (1996) (32)
- Preliminary evidence of an association between increased REM density and poor antidepressant response to partial sleep deprivation. (2000) (31)
- The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness (1991) (31)
- Training Psychiatric Residents and Fellows in a Telepsychiatry Clinic: A Supervision Model (2008) (30)
- Relationship of mood disturbance to cigarette smoking status among 252 patients with a current mood disorder. (2001) (30)
- Studies characterizing 60 kda autoantibodies in subjects with schizophrenia (2003) (30)
- Beneficial Effects of Nalmefene Augmentation in Neuroleptic-Stabilized Schizophrenic Patients (1993) (29)
- Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses (2015) (28)
- Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients (1989) (28)
- Sertraline treatment of panic disorder: response in patients at risk for poor outcome. (2000) (28)
- Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia. (1994) (28)
- A comparison of ICD-10 and DSM-III-R criteria for substance abuse and dependence. (1993) (27)
- Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study. (2012) (27)
- Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins (2005) (27)
- Sertraline treatment of panic disorder: results of a long-term study. (2001) (26)
- Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial. (2009) (26)
- Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder. (1989) (25)
- Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders (2020) (25)
- Effects of Rapid Tryptophan Depletion on Sleep Electroencephalogram and Mood in Subjects with Partially Remitted Depression on Bupropion (2002) (25)
- A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. (2012) (25)
- The role of dopaminergic agents in improving quality of life in major depressive disorder (2009) (24)
- Insomnia and suicidal ideation in nonaffective psychosis (2018) (24)
- The cholinergic REM sleep induction test with pilocarpine in mildly depressed patients and normal controls (1993) (24)
- Prognostic value of polygenic risk scores for adults with psychosis (2021) (24)
- The effects of prolonged lithium exposure on the immune system of normal control subjects: Serial serum soluble interleukin-2 receptor and antithyroid antibody measurements (1994) (23)
- A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders. (1996) (23)
- Haloperidol and soluble interleukin-2 receptors (1991) (23)
- The effects of celecoxib augmentation on cytokine levels in schizophrenia. (2006) (22)
- Acute Swedish Massage Monotherapy Successfully Remediates Symptoms of Generalized Anxiety Disorder: A Proof-of-Concept, Randomized Controlled Study. (2016) (22)
- Translating the evidence on atypical depression into clinical practice. (2007) (22)
- Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls (1998) (21)
- An open-label study of SSRI treatment in depressed hispanic and non-Hispanic women. (1997) (21)
- Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. (2020) (20)
- Analysis of GNAZ gene polymorphism in bipolar affective disorder. (1999) (19)
- An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients (1997) (19)
- Non-invasive vagal nerve stimulation decreases brain activity during trauma scripts (2020) (18)
- Methodologies and outcomes from the sertraline multicenter flexible-dose trials. (1998) (18)
- A psychiatric staff response to acquired immune deficiency syndrome. (1986) (17)
- The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis. (2013) (17)
- Correlates of functioning in bipolar disorder. (2008) (16)
- Transcutaneous vagal nerve stimulation blocks stress-induced activation of Interleukin-6 and interferon-γ in posttraumatic stress disorder: A double-blind, randomized, sham-controlled trial (2020) (15)
- Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. (2013) (15)
- Massage Therapy for Psychiatric Disorders. (2018) (15)
- Quality of Life in Geriatric Patients with Mood and Anxiety Disorders (2003) (15)
- Treatment Options in Treatment-Resistant Depression (2005) (15)
- Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD) (2018) (14)
- An Abbreviated Review of Immune Abnormalities in Schizophrenia (2001) (14)
- Trait contributions of complex dysregulated behavioral organization in schizophrenic patients (2001) (14)
- False-positive human immunodeficiency virus type I ELISA results in low-risk subjects. (1993) (13)
- Vagus Nerve Stimulation: Back to the Future. (2017) (13)
- Treatment of functional neurological disorder: current state, future directions, and a research agenda (2020) (12)
- Acquired immunodeficiency syndrome presenting as schizophrenia. (1987) (12)
- A comparison of demographic variables, symptom profiles, and measurements of functioning in symptomatic volunteers and an outpatient clinical population. (1995) (12)
- Building an evidence base in complementary and integrative healthcare for child and adolescent psychiatry. (2013) (12)
- Application of external review for subject selection in a schizophrenia trial. (2012) (12)
- Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals. (2004) (11)
- A review of social phobia. (1995) (11)
- Psychiatric workforce needs and recommendations for the community mental health system: a state needs assessment. (2015) (10)
- Parental type 2 diabetes in patients with non-affective psychosis (2016) (10)
- Serial Mitogen-Stimulated Cytokine Production from Continuously Ill Patients with Schizophrenia (2010) (10)
- Conflict of interest, round 2. (2006) (10)
- Neuroendocrine effects of intravenous ovine corticotropin-releasing factor in affective disorder patients and normal controls (1988) (10)
- Chronic pain and posttraumatic stress disorder. (1987) (10)
- Alprazolam and hostility. (1985) (9)
- Corrigendum to “Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores” [Schizophrenia Research 71 (1) (2004) 155–165] (2005) (9)
- Amnesia and neonaticide. (2002) (9)
- AIDS and homosexual panic. (1985) (9)
- Economics of depression and cost‐benefit comparisons of selective serotonin reuptake inhibitors and tricyclic antidepressants (1994) (8)
- Quality of Life Impairment in Anxiety Disorders (2007) (8)
- Rapid Tryptophan Depletion Plus a Serotonin 1A Agonist: Competing Effects on Sleep in Healthy Men (2001) (8)
- 6th International Conference on the Reduction of Drug-Related Harm (1996) (8)
- Characterisation of age and polarity at onset in bipolar disorder (2021) (7)
- Mothers murdering their newborns in the hospital. (2000) (7)
- A Novel Peripheral Biomarker for Depression and Antidepressant Response (2021) (7)
- Major Depressive Disorder and Suicide (2008) (7)
- The effectiveness of atypical antipsychotic medications in depressive disorders (2004) (7)
- Time to response in generalized anxiety disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone. (2006) (7)
- Panic disorder in a managed care environment. (1997) (7)
- Clinicians on the front line: active management of depression and anxiety in primary care. (2006) (7)
- Mood Disorders (2018) (6)
- Current Role of Herbal and Natural Preparations. (2019) (6)
- Transderm scopolamine efficacy related to time of application prior to the onset of motion. (1985) (6)
- Comparison of descriptive variables for symptomatic volunteers and clinical patients with anxiety disorders. (1996) (6)
- The diagnosis and treatment of generalized anxiety disorder (2005) (6)
- WHAT IS SUBSYNDROMAL SYMPTOMATIC DEPRESSION (SSD) (1994) (5)
- Six versus twelve weeks of Swedish massage therapy for generalized anxiety disorder: Preliminary findings. (2020) (5)
- Transcutaneous Cervical Vagal Nerve Stimulation in Patients with Posttraumatic Stress Disorder (PTSD): A Pilot Study of Effects on PTSD Symptoms and Interleukin-6 Response to Stress (2021) (5)
- The effects of physostigmine infusion on patients with panic disorder (1991) (5)
- From the Editors of FOCUS (2012) (4)
- Panic Disorder and Response to Sertraline: The Effect of Previous Treatment with Benzodiazepines (2001) (4)
- The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program (2019) (4)
- Long-term antidepressant treatment. (2002) (4)
- Researcher experiences with IRBs: a survey of members of the American College of Neuropsychopharmacology. (2011) (4)
- Model structure for protocol adherence utilizing a manualized therapeutic massage intervention (2018) (4)
- A simple question answered: adding moderate-dosage lithium does not help patients with bipolar disorder. (2013) (4)
- Polyunsaturated Fatty Acids in Adult Psychiatric Disorders: A Comprehensive Overview (2015) (3)
- Psychiatry's modern role in functional neurological disorder: join the renaissance (2021) (3)
- Requests by walk-in and scheduled patients at an outpatient clinic. Walk-in needs more varied and greater in number. (1987) (3)
- Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial. (2022) (3)
- Focus major depressive disorder : maintenance of certification workbook (2013) (3)
- When Should a Patient Be Declared Recovered From a Major Depressive Episode? (2016) (3)
- Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders (2021) (3)
- Diet not shown effective in psoriasis. (1981) (3)
- Patients' preference for complementary and alternative medicine presents challenges for research. (2015) (3)
- The efficacy of new pharmacological treatments for panic disorder: evaluating the trials. (1998) (3)
- Beyond acute treatment of depressive disorders. (2009) (3)
- Antidepressant signal detection in the clinical trials vortex. (2015) (3)
- Future Drugs for the Treatment of Depression: The Need to Look Beyond Monoamine Systems (2009) (3)
- Psychiatry Departments Under Constrained Funding Mechanisms or What Is a Chairperson to Do? (2016) (3)
- Erratum: Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation (Neuropsychopharmacology (2006) 31, 2505-2513) DOI: 10.1038/sj.npp.1301113 (2006) (3)
- Review of the diagnosis and treatment of major depression for the non‐mental health professional (1995) (2)
- 10. The interaction between the immune system and psychiatric disorders (2000) (2)
- Residential treatment for patients in crisis. (1998) (2)
- Adapting to Decreased Industry Support of CME: Lifelong Education in an “Industry-Lite” World (2011) (2)
- Serotonin receptors, social phobia and panic disorder (1995) (2)
- Review of the diagnosis and treatment of major depression for the non‐mental health professional (1995) (2)
- PTSD and quality of life: Results of 64 weeks of sertraline treatment (2001) (2)
- Relapse Prevention and Bipolar Disorder: A Focus on Bipolar Depression (2003) (2)
- Early response to sertraline as a predictor of 12-week outcome in panic disorder (1998) (2)
- Carbon-dioxide-induced panic. (1994) (2)
- Does Massage Therapy affect Brain Metabolites (2007) (2)
- Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression (2002) (2)
- The Surgeon Who Operated on Himself (2011) (2)
- Helping patients with depression achieve wellness. (2009) (2)
- National Depression Screening Day: the San Diego experience. (1994) (2)
- A preliminary analysis investigating immune activation in schizophrenia (1999) (2)
- Psychopharmacology and psychotherapy of subsyndromal depressions (2004) (1)
- Preliminary communication Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment (1998) (1)
- Panic disorder (2001) (1)
- Missed psychiatric appointments. (1994) (1)
- The Genetics of Obsessive-Compulsive Disorder: An Immunologic Perspective (1999) (1)
- Teaching the teacher: a report from the third annual American Society of Clinical Psychopharmacology teaching session. (2013) (1)
- Factors influencing outpatient attrition. (1988) (1)
- Emerging Treatment Options in Treatment-Resistant Depression and Anxiety Disorders (2002) (1)
- Polygenic risk scores lack prognostic value for adults with severe mental illness (2021) (1)
- Panic disorder in a managed care environment. Discussion (1997) (1)
- Vagus Nerve Stimulation for Treatment-ResistantDepression: A Randomized, Controlled AcutePhase Trial (2005) (1)
- Paroxetine Controlled Release (2004) (1)
- The Role of Subsyndromal Depressive Symptoms in Unipolar Major Depression (1998) (1)
- Possible loci for bipolar disorder on chromosome 5 near the dopamine transporter locus and on chromosome 22 (1996) (1)
- Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators (2023) (1)
- Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy (2014) (1)
- Characterization of Age and Polarity at Onset in Bipolar Disorder (2021) (1)
- An agenda for functional neurological disorders: care and research (2020) (1)
- NIMH bulletins and redundant publication (1991) (1)
- Locus Coeruleus Noradrenergic Modulation of Diurnal Corticosterone, Stress Reactivity, and Cardiovascular Homeostasis in Male Rats (2021) (1)
- The United States index of socioeconomic deprivation for individuals (USiDep) (2022) (1)
- Beyond the Psychiatric Horizon: Preparing Residents for the Twenty-First Century (2017) (1)
- Longitudinal study of inflammation and relapse in schizophrenia (2023) (0)
- Abstracts from the 2019 International Massage Therapy Research Conference (2019) (0)
- PMH52 IMPROVEMENT IN QUALITY-OF-LIFE WITH RISPERIDONE AUGMENTATION IN TREATMENT-RESISTANT DEPRESSION (2004) (0)
- Measuring quality of life in patients with panic disorder (2003) (0)
- From the Editors: An Introduction to FOCUS (2003) (0)
- New Clinical Drug Evaluation Unit (NCDEU) annual meeting: a great opportunity for early career psychiatrists. (2012) (0)
- Lori L. Altshuler, MD 1957-2015. (2016) (0)
- Introduction—Treatment Resistance: Concepts and Management in Mood and Anxiety Disorders (2002) (0)
- A comparison Of descriptive characteristics of male outpatients and inpatients with affective disorders (1998) (0)
- Use of a relapse monitoring board: an independent assessment for determining relapse in clinical trials for bipolar disorder. (2011) (0)
- Effect of pharmacotherapy on suicidal ideation and behavior (1994) (0)
- Reply: Symptomatic Volunteers Different From Patients With Depressive Disorders? (1997) (0)
- Research diagnostic problems. (1987) (0)
- Book Review Panic Disorder and Its Treatment (Medical Psychiatry.) Edited by Jerrold F. Rosenbaum and Mark H. Pollack. 353 pp. New York, Marcel Dekker, 1998. $99.75. 0-8247-0216-6 (1998) (0)
- Succinylcholine Chloride the Mood-lowering Effect of Tryptophan Depletion: Possible Explanation for Discrepant Findings (2008) (0)
- Chapter 106: Anxiolytic drugs (2015) (0)
- The Relationship Between Major Depressive Disorder and Multiple Medical Conditions: A Call to Improve Integrated Care Services. (2022) (0)
- 106. Anxiolytic Drugs (2015) (0)
- A preliminary descriptive report of the longevity of the effects of Swedish Massage therapy for subjects with Generalized Anxiety Disorder. (2022) (0)
- Efficacy, Safety, and Tolerability Considerations in the Novel Treatment of Major Depressive Disorder (2009) (0)
- Focus psychiatry review : 400 self-assessment questions (2007) (0)
- Commentary: Burden of phobias: Focus on health-related quality of life. (2004) (0)
- A Descriptive Analysis of Minor Depression (2005) (0)
- Dose-Dependent Effects of EPA Supplementation on Plasma Specialized Pro-Resolving Mediators in Major Depressive Disorder Patients with Chronic Inflammation (2020) (0)
- ALTERATIONS IN IMMUNE PARAMETERS IN PSYCHOSIS (1992) (0)
- 127. The identification of a putative 60 kDa autoantibody in schizophrenia (2000) (0)
- DETAILED STUDY PROTOCOL TITLE: Omega-3 Fatty Acids for MDD with High Inflammation: A Personalized Approach (2019) (0)
- 227. Immune system activation and motor dysfunction in schizophrenia (1998) (0)
- Subject Index Vol. 77, 2008 (2008) (0)
- Comparison of Mood Ratings and Comorbid Diagnoses in Research Subjects with Major Depression or Stimulant Dependence (1996) (0)
- Dose- and time-dependent increase in circulating antiinflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation (2021) (0)
- Official Actions Executive Summary (0)
- ECP news. The new investigator program at the NCDEU meeting: opportunities found for all. (2009) (0)
- Introducing a New Section: The Applied Armamentarium. (2017) (0)
- NEW SUBTYPES OF DEPRESSION: IMPLICATIONS FOR RESEARCH (1994) (0)
- Setting a Research Agenda for FND. (2020) (0)
- Qualifications for recertification: an important but evolving set of standards. (2008) (0)
- Response to Dr Bernard Carroll (2008) (0)
- 128. Use of objective measures of motor function to differentiate olanzapine and risperidone (2000) (0)
- Does n-3 Fatty Acid Supplementation Impact Immune and Clinical Outcomes in Inflammatory Depression? (2020) (0)
- Gender and Addiction – Prevalence, Course and Treatment (1996) (0)
- Contents Vol. 77, 2008 (2008) (0)
- PD47-11 LONGITUDINAL IMPACT OF BLADDER CANCER DIAGNOSIS ON COMMON PSYCHIATRIC DISORDERS (2021) (0)
- Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mark Hyman Rapaport?
Mark Hyman Rapaport is affiliated with the following schools:
